[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593932":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":24,"locations":12,"responsibleParty":34,"collaborators":12,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":12,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":12,"enrollmentInfo":45,"targetDuration":12,"studyType":48,"phases":49,"briefSummary":51,"conditions":52,"keywords":12,"overallStatus":59,"whyStopped":12,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":12},{"fullName":5,"class":6},"Vastra Gotaland Region","OTHER_GOV",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard care","NO_INTERVENTION","Patients randomized to this arm will get standard treatment within the ambulance service",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Dry plasma","ACTIVE_COMPARATOR","Patients randomized to this arm will get dry plasma as treatment for the bleeding.",[18],"Biological: Dry plasma",[20],{"type":21,"name":14,"description":22,"armGroupLabels":23,"otherNames":12},"BIOLOGICAL","Patient that fulfil the inclusion criteria for this study and are randomized for active treatment will get dry plasma as intervention.",[14],[25,30],{"name":26,"role":27,"phone":28,"phoneExt":12,"email":29},"Göran Sandström, PhD","CONTACT","+46760181284","goran.sandstrom@gu.se",{"name":31,"role":27,"phone":32,"phoneExt":12,"email":33},"Gabriel Skallsjö, MD","+46705683196","gabriel.skallsjo@vgregion.se",{"type":35,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100593932","phase-4-life-saving-treatment-with-dry-plasma-for-massive-bleeding-in-an-pre-hospital-setting-100593932",false,"NCT07012863","Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting","Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting - - a Randomized Controlled Study","Inclusion Criteria:\n\n* Patients with clinical signs of bleeding which also triggers resuscitation with crisalloids acording to standard care protocol.\n\nExclusion Criteria:\n\n* Patients \\\u003C 18 years of age.\n* Patients who lack clinical signs of major bleeding.","ALL","18 Years",{"count":46,"type":47},650,"ESTIMATED","INTERVENTIONAL",[50],"PHASE4","The overall goal of this clinical trial is to study how prehospital transfused dry plasma affect outcomes in terms of mortality as well as complications and coagulation status of patients in or about to develop bleeding shock.\n\nResearchers will compare dry plasma to standard care to see if dry plasma improves survival compared to crystalloid fluid in prehospital patients with heavy bleeding.",[53,54,55,56,57,58],"Bleeding","Aortic Rupture","Gastrointestinal Hemorrhage","Obstetric Bleeding","Blunt Injury","Penetrating Injury","NOT_YET_RECRUITING","2025-09-16",{"date":62,"type":63},"2025-09-17","ACTUAL",{"date":65,"type":47},"2026-01-01",{"date":67,"type":47},"2027-09-30",{"name":5,"class":6}]